|
Market Closed -
Other stock markets
|
After hours 01:00:00 | |||
| 116.86 USD | +2.68% |
|
116.53 | -0.28% |
| 06-30 | FDA clears Orca's blood cancer therapy to reduce stem cell transplant complications | RE |
| 06-29 | Incyte Corporation(NasdaqGS:INCY) dropped from Russell Midcap Growth Benchmark | CI |
| Market Cap | 23.35B 20.4B 18.73B 17.47B 33.12B 2,223B 33.68B 226B 87.41B 1,090B 87.66B 85.76B 3,756B | P/E 2026 * |
17x | P/E 2027 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 18.33B 16.01B 14.71B 13.71B 26B 1,745B 26.44B 177B 68.62B 856B 68.82B 67.32B 2,949B | EV / Sales 2026 * |
3.25x | EV / Sales 2027 * | 2.65x |
| Free-Float |
98.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Incyte Corporation
| 1 day | +2.68% | ||
| 1 week | +8.68% | ||
| Current month | +3.09% | ||
| 1 month | +26.69% | ||
| 3 months | +21.82% | ||
| 6 months | +15.22% | ||
| Current year | +18.32% |
| 1 week | 112.8 |  | 118.69 |
| 1 month | 96.09 | | 118.69 |
| Current year | 89.25 | | 118.69 |
| 1 year | 66.85 | | 118.69 |
| 3 years | 50.27 | | 118.69 |
| 5 years | 50.27 | | 118.69 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 25/06/2025 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 03/05/2026 |
Pablo Cagnoni
PSD | President | 62 | 04/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 25/06/2025 |
| Director/Board Member | 72 | 19/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 19/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-07 | Free | Director | 7,753 | 0.0039% | ||
| 06-07 | Other | Director | 0 | 0% | ||
| 06-07 | Free | Director | 7,753 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.68% | +8.68% | +71.42% | +87.73% | 23.35B | |
| +4.73% | +5.50% | +19.45% | -8.94% | 66.56B | |
| -0.04% | +2.09% | +61.31% | +231.87% | 57.64B | |
| +0.72% | +40.60% | +40.60% | +40.60% | 42.24B | |
| +3.45% | +6.04% | -49.46% | -55.91% | 39.09B | |
| +3.04% | +7.01% | +62.26% | -24.13% | 31.91B | |
| +10.01% | +33.49% | +163.41% | -34.35% | 31.65B | |
| +2.17% | +16.17% | +3.19% | +191.00% | 18.92B | |
| +0.52% | +2.04% | +68.04% | +127.95% | 17.17B | |
| +3.58% | +10.76% | +80.22% | +348.78% | 15.12B | |
| Average | +3.07% | +8.38% | +52.05% | +90.46% | 34.37B | |
| Weighted average by Cap. | +3.05% | +7.49% | +46.20% | +68.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.65B 4.93B 4.53B 4.22B 8.01B 537B 8.14B 54.54B 21.14B 264B 21.2B 20.74B 908B | 6.22B 5.43B 4.99B 4.65B 8.82B 592B 8.97B 60.07B 23.28B 290B 23.34B 22.84B 1,000B |
| Net income | 1.44B 1.26B 1.15B 1.08B 2.04B 137B 2.07B 13.88B 5.38B 67.11B 5.4B 5.28B 231B | 1.67B 1.46B 1.34B 1.25B 2.37B 159B 2.41B 16.17B 6.27B 78.16B 6.28B 6.15B 269B |
| Net Debt | -5.02B -4.39B -4.03B -3.76B -7.12B -478B -7.24B -48.49B -18.79B -234B -18.84B -18.44B -808B | -6.87B -6.01B -5.52B -5.14B -9.75B -654B -9.92B -66.41B -25.74B -321B -25.81B -25.25B -1,106B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | US$116.86 | +2.68% | 2,632,596 |
| 01/07/26 | US$113.81 | +0.40% | 1,711,033 |
| 30/06/26 | US$113.36 | -1.13% | 1,830,643 |
| 29/06/26 | US$114.66 | +0.80% | 1,532,380 |
| 26/06/26 | US$113.75 | +5.78% | 3,795,266 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
